Network
Hypo-RESOLVE unites leading healthcare players as well as patient organisations from all over Europe and the United States

CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER (CHUM)
France

CHUM is the 6th largest French public hospital, affiliated with the University of Montpellier. The Department of Endocrinology, Diabetes and Nutrition is involved in the development and assessment of innovative technologies dedicated to diabetes care, including portable and implantable insulin pumps, continuous glucose monitoring (CGM) systems, artificial pancreas (AP) models, as well as pancreas and islet transplantations. It holds a specific unit for education and follow-up of patients using technologies for diabetes care.

CHUM will lead a systematic review from literature search and contacts with public and industrial research teams on glucose monitoring technologies under development that could cover gaps of current systems in the detection of hypoglycemia and its outcomes. CHUM will further act as a key-investigator site in the clinical study aiming at the identification of hypoglycemia patient related outcomes, as well as societal and economic impacts of hypoglycemia. CHUM will also participate in the updated definitions and classification of hypoglycemia which are expected important outcomes of the project.

Prof. Eric Renard, MD

holds a Chair of Professor of Endocrinology, Diabetes & Metabolism at Montpellier Medical School, University of Montpellier, since 1999, and the Head of the Department of Endocrinology, Diabetes and Nutrition, at Lapeyronie University Hospital, Montpellier, since 2010. Eric Renard is also Medical Director of Clinical Research at Montpellier University Hospital since November 2008 and Head of the INSERM Clinical Research Centre at Montpellier University Hospital since January 2010. He leads a research team focusing on ‘Determinants and correction of the loss of insulin secretion in diabetes’ at the Institute of Functional Genomics, UMR CNRS 5203/INSERM U1191/ University of Montpellier, Montpellier, since 2012.

Dr Anne Farret, MD

holds a position of Senior Clinical Research investigator at Montpellier University Hospital in the Department of Endocrinology, Diabetes and Nutrition. She has a broad expertise in the evaluation of medical devices dedicated to diabetes monitoring, therapy and control, including insulin pumps, CGM systems and artificial pancreas in outpatients.

Jérôme Place, MSc

is a research engineer at the Institute of Functional Genomics, UMR CNRS 5203/INSERM U1191/ University of Montpellier, Montpellier, working in the team led by Prof. Renard. He is coordinator of many clinical studies dedicated to diabetes technology and has developed remote monitoring systems used for the investigation of outpatients testing artificial pancreas systems. He is also data manager of multicentre clinical studies of insulin delivery and CGM systems and holds ability of statistical analyses.

Dr Omar Diouri

holds a Master from Mines-Telecom School (Paris, France) in Information & Communication Technologies applied to healthcare. He is a specialist in the development of mobile applications for diabetes management and acquired an experience of clinical research assistant for studies in the field of diabetes technology during his post-doctoral fellowship at MedBioMed, an SME dedicated to clinical trials in Montpellier, France.

University of Cambridge
University of Southern Denmark